-
Small Cell SMASHERS Fireside Chat with Dr. Catherine Meador
In April, we were joined by Catherine Meador, MD, PhD, assistant professor of medicine at Harvard Medical School. Dr. Meador discussed Transformed SCLC: Understanding Biology, Detection, and...
IN THE SPOTLIGHT
-
Clinical Trial Access Isn’t Expanding. It’s Concentrating.
Clinical trials show us whether a new treatment is safe and effective. They are also an important way for patients to access cutting-edge care. For trials to truly serve the lung... -
Podcast: Lung Cancer Diagnosis—What Happens Next
What happens after a lung cancer diagnosis? In this first episode of LUNGevity’s Lung Cancer Voices of Hope podcast, lung cancer survivor Lisa Bistline shares her experience, from... -
Explaining BiTE® Therapy
A bi-specific T-cell engager (BiTE®) is a new type of engineered molecule used for the treatment of cancer. These molecules harness and activate T-cells, which are involved in the... -
Podcast: Why Community Matters in Lung Cancer Care
Why does finding community matter in lung cancer care? In this episode, lung cancer survivor and advocate Jill Feldman shares her experience, from losing multiple family members to... -
Small Cell SMASHERS Fireside Chat: Who's Up Next?
Small Cell SMASHERS Fireside Chat with Dr. Simon Heeke Join us for a YouTube Live on Friday, May 15, with Simon Heeke, PhD, MD Anderson Cancer Center. Dr. Heeke will discuss... -
Scalp Care, Shaving, and Head Coverings: Comfort Through Hair Loss
This video is a recording from a LUNGevity virtual meetup. Each month, we host multiple virtual meetups for those impacted by lung cancer to meet and connect with others who... -
Meet The “Mini-Organs” of Lung Cancer Research
Though many of us would like to deny it, our neighbors affect us. Their loud music disturbs our sleep. The scent of their dinner wafts through an open window. The sight of their... -
SCLC Virtual Meetup
SCLC patients/survivors - Join us the 3rd Wednesday of every month to c onnect with others who share common experiences and build your community. Register in advance for this... -
Small Cell SMASHERS Fireside Chat with Dr. Laura Alder
In March, we were joined by Laura Alder, MD, assistant professor of medicine in the Division of Medical Oncology at Duke University Medical Center, to discuss the topic of managing...
TCE TALK 巅峰对话｜吴一龙 & Luis Paz-Ares 中外论道：塔拉妥单抗破局SCLC，开启定向免疫新纪元_肺癌_塔拉妥单抗_医脉通
Zepzelca Fails to Meet Main Goal of Phase III Lagoon Trial in Second-Line Small Cell Lung Cancer
Zepzelca Fails to Meet Main Goal of Phase III Lagoon Trial in Second-Line Small Cell Lung Cancer
Lurbinectedin Misses Survival Endpoint in Relapsed SCLC Trial
Topline LAGOON Results Show Missed OS End Point With Lurbinectedin in Relapsed SCLC
Jazz Pharma's Zepzelca Misses Primary Endpoint in Second-Line Lung-Cancer Trial
Jazz Pharmaceuticals Reveals Phase 3 Trial Results for Zepzelca in Small Cell Lung Cancer, Missing Survival Endpoint
Jazz Pharmaceuticals Reveals Phase 3 Trial Results for Zepzelca in Small Cell Lung Cancer, Missing Survival Endpoint
Family to cycle 250km in memory of 'devoted dad' who sadly died from cancer
New Lung Cancer Study Findings Have Been Reported by Researchers at Cancer Institute Hospital of Japanese Foundation for Cancer Research (Real-World Survival Over 25 Years...
New Lung Cancer Study Findings Have Been Reported by Researchers at Cancer Institute Hospital of Japanese Foundation for Cancer Research (Real-World Survival Over 25 Years...
U.S. Clinical Trial: Yonsei University Listed a New Clinical Trial to Study Lurbinectedin Plus Paclitaxel Versus Paclitaxel in Patients With Previously Treated Small Cell Lung...
U.S. Clinical Trial: Yonsei University Listed a New Clinical Trial to Study Lurbinectedin Plus Paclitaxel Versus Paclitaxel in Patients With Previously Treated Small Cell Lung...
Efficacy and safety of nab-paclitaxel in advanced or recurrent small cell lung cancer: a single-arm meta-analysis
Efficacy and safety of nab-paclitaxel in advanced or recurrent small cell lung cancer: a single-arm meta-analysis